as on February 12, 2026 at 7:59 am IST
Day's Low
Day's High
2.41%
Downside
0.59%
Upside
52 Week's Low
52 Week's High
23.01%
Downside
13.14%
Upside
Check Resmed Inc. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$37.3B
EPS (TTM)
10.9182
Dividend Yield
0.81%
Quarterly Earnings Growth YOY
0.14%
PE Ratio (TTM)
26.18
Industry PE ratio
20.958441558441557
PEG Ratio
1.6493
EBITDA
2.0B
Revenue (TTM)
5.4B
Profit Margin
27.35%
Return On Equity TTM
25.41%
Track how Resmed Inc. P/E has moved over time to understand its valuation trends.
Resmed Inc. in the last 5 years
Lowest (22.59x)
December 31, 2023
Industry (20.96x)
February 11, 2026
Today (26.18x)
February 11, 2026
Highest (49.09x)
September 30, 2021
Today’s Price to Earnings Ratio: 26.18x
Compare market cap, revenue, PE, and other key metrics of Resmed Inc. with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
|---|---|---|---|---|---|
| BUY | $37.3B | 31.42% | 26.18 | 27.35% | |
| BUY | $189.6B | 85.95% | 67.11 | 28.38% | |
| BUY | $39.8B | 7.81% | 38.47 | 10.28% | |
| BUY | $58.1B | -32.25% | 34.95 | 7.68% | |
| NA | $33.9B | NA | 62.4 | 4.62% |
The Resmed Inc. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Resmed Inc. investment value today
Current value as on today
₹1,13,799
Returns
₹13,799
(+13.8%)
Returns from Resmed Inc. Stock
₹9,371 (+9.37%)
Dollar Returns*
₹4,428 (+4.43%)
Based on 19 analysts
63.16%
Buy
36.84%
Hold
0.00%
Sell
Based on 19 analysts, 63.16% of analysts recommend a 'BUY' rating for Resmed Inc.. Average target price of $297.47
Get share price movements and forecasts by analysts on Resmed Inc..
What analysts predicted
12.7%UPSIDE
Target Price
$297.47
Current Price
$259.68
Analyzed by
19 Analysts
Target
$297.47
Resmed Inc. target price $297.47, a slight upside of 12.7% compared to current price of $259.68. According to 19 analysts rating.
Search interest for Resmed Inc. Stock has decreased by -15% in the last 30 days, reflecting a downward trend in search activity.
Time period: to
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
Today's Timeline - 10 February
Tue, 02:33 PM
-ResMed's 2026 outlook strengthens with FDA clearance for AI-enabled CPAP device and strong revenue growth.
Tue, 10:13 PM
-ResMed reports Q2 fiscal 2026 EPS of $2.81, beating estimates by 46%, with revenues of $1.42 billion.
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Profit Spike
![]()
Resmed Inc. has seen a steady increase in its net profit over the last two quarters. In the most recent quarter, the net profit rose to $392.59 million, up from $348.53 million in the previous quarter. This represents an average increase of 11.2% per quarter.
Revenue Rich
![]()
Resmed Inc. has shown a positive revenue trend over the last two quarters. The company reported a revenue increase from $1.33 billion to $1.42 billion, reflecting an average growth of 6.1% per quarter.
Price Rise
![]()
In the last 1 month, RMD stock has moved up by 4.4%
Best in 1 Year
![]()
In the last 1 year, RMD has outperformed top 5 stocks with highest market-cap in its industry
Best in 3 Years
![]()
In the last 3 years, RMD has outperformed top 5 stocks with highest market-cap in its industry
| Organisation | Resmed Inc. |
| Headquarters | 9001 Spectrum Center Boulevard, San Diego, CA, United States, 92123 |
| Industry | Health Technology |
| CEO | Mr. Michael J. Farrell BE, MBA, SM |
| E-voting on shares | Click here to vote |
Name | Title |
|---|---|
Ms. Vered Keisar | Chief People Officer |
Mr. Alastair Robertson | Chief Information Officer |
Ms. Sallilyn Schwartz | Chief Investor Relations Officer |
Mr. Jim Ellis | Chief Compliance Officer |
Mr. Michael J. Farrell BE, MBA, SM | CEO & Chairman |
Dr. Peter C. Farrell A.M., B.E., BE (Hons), Ph.D., ScD | Founder, Chair Emeritus & Non-Executive Director |
Mr. Brett A. Sandercock | Chief Financial Officer |
Mr. Michael J. Rider | Chief Legal Officer & Secretary |
Mr. Justin Leong | Chief Product Officer |
Ms. Yvonne-Katrin Pucknat | Chief Marketing Officer |
Resmed Inc. share price today is $259.68 as on at the close of the market. Resmed Inc. share today touched a day high of $261.2 and a low of $253.42.
Resmed Inc. share touched a 52 week high of $293.81 on and a 52 week low of $199.92 on . Resmed Inc. stock price today i.e. is closed at $259.68,which is 11.62% down from its 52 week high and 29.89% up from its 52 week low.
Resmed Inc. market capitalisation is $0.04T as on .
Indian investors can start investing in Resmed Inc. (RMD) shares with as little as ₹90.637 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹906.37 in Resmed Inc. stock (as per the Rupee-Dollar exchange rate as on ).
Based on Resmed Inc. share’s latest price of $259.68 as on February 12, 2026 at 2:29 am IST, you will get 0.0385 shares of Resmed Inc.. Learn more about
fractional shares .
Resmed Inc. stock has given 31.42% share price returns and 24.82% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?